Table 3.
Lixisenatide | Placebo | |||
---|---|---|---|---|
Sulfonylurea use at screening | Yes (n = 108) | No (n = 46) | Yes (n = 111) | No (n = 46) |
Patients with symptomatic hypoglycaemia, n (%) | 51 (47.2%) | 15 (32.6%) | 24 (21.6%) | 13 (28.3%) |
Events / patient year, n | 3.54 | 1.48 | 1.48 | 1.36 |
Patients with blood glucose <60 mg/dl, n (%) | 46 (42.6%) | 13 (28.3%) | 21 (18.9%) | 11 (23.9%) |